This inventor holds 9 USPTO granted patents, plus 2 CIPO patents and 5 EPO patents. Top assignees: Meiji Seika Pharma Co., Ltd., Mitsui Chemicals, Inc., Meui Seika Kaisha, Ltd.. Active years: 2009-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Yokohama, JP (2009 - 2018)
- Odawara, JP (2015 - 2018)
- Kanagawa, JP (2018 - 2020)
Company Filing History:

Years Active: 2009-2020
Title: The Innovative Contributions of Fumikazu Yokoyama
Introduction
Fumikazu Yokoyama, a prominent inventor based in Yokohama, Japan, has made significant strides in the field of biochemistry with nine patents to his name. His innovative work focuses on cellulase genes and their applications, showcasing his dedication to advancing scientific knowledge and practical uses in biotechnology.
Latest Patents
Among Fumikazu's latest patents is the identification of endoglucanase and β-glucosidase genes through the isolation of genomic DNA. This invention involves sequencing nucleotide sequences of these genes and comparing amino acid sequences to identify conserved regions. By designing various primers and conducting Polymerase Chain Reaction (PCR), Fumikazu successfully amplified nine genes associated with endoglucanases and β-glucosidases. Another noteworthy patent focuses on a novel, highly hydrophobic β-glucosidase identified through advanced chromatography techniques. The corresponding gene's base sequence was modified and expressed at high levels, demonstrating effective β-glucosidase activity, which has important implications in various industrial applications.
Career Highlights
Fumikazu Yokoyama has built a reputable career working with leading companies such as Meiji Seika Pharma Co., Ltd. and Mitsui Chemicals, Inc. His expertise in biotechnology has positioned him as a valuable asset in these organizations, contributing to their research and product development efforts.
Collaborations
Throughout his career, Fumikazu has collaborated with esteemed colleagues like Kaoru Okakura and Atsushi Inoue. Their combined efforts foster innovation and knowledge exchange in their respective fields, further enhancing the impact of their work on biotechnology and genetic research.
Conclusion
Fumikazu Yokoyama's impressive portfolio of patents highlights his significant contributions to the field of biotechnology, particularly in the understanding and application of cellulase genes. His collaborations and career trajectory reflect a commitment to advancing science and technology, demonstrating the vital role that inventors play in shaping our understanding and utilization of biological systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile